-
-
Pharma & Human Health -
Pharma & Human Health -
Finance -
Pharma & Human Health
Editor’s Choice
Editor's Choice
“Probiotics” Green-lit for market-usage by French Authorities
In a letter to the National Union of Food Supplements, the Direction générale de la consommation, de la concurrence et de la répression des fraudes (DGCCRF) outlined that supplements can use the term so long […]
Editor's Choice
Microbiome Drug Development: 2022 in Review
Leveraging a year of important research updates, funding rounds, and academic papers, this report compiles the most significant industry news pertaining to microbiome drug development in 2022. It finds that the regulatory approval of three […]
In Case you Missed it:
Pharma & Human Health
University of Pittsburgh lab shows phage attacks in new light
As antibacterial resistance continues to render obsolete the use of some antibiotics, some have turned to bacteria-killing viruses to treat acute infections as well as some chronic illnesses. Graham Hatfull, the Eberly Family Professor of […]
Pharma & Human Health
Colorectal cancer surgery: Gut microbiota helps healing
Published in the journal Gut, the study by scientists at the CHUM Research Centre (CRCHUM) in Montreal identified two bacterial strains that directly affect whether or not anastomotic leakage, more commonly known as intestinal leakage, […]
Finance
Biose Industrie announces the opening of new manufacturing development facility in Boston, MA
Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, announced today their plan to open a laboratory in the heart of Boston, Massachusetts, later […]
Finance
Biose Industrie to receive €80M in investment to boost workforce and manufacturing capabilities
L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a world leader in the development and production of […]
Pharma & Human Health
Regulatory pathway needs to be developed to make the most of phages
A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage […]
Finance
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding. This follows Prokarium’s announcement of partnering with Ginkgo Bioworks to leverage its world-class Foundry and extensive Codebase […]
Finance
ADM Opens More Than $30 Million State-of-the-Art Production Facility in Spain
ADM (NYSE: ADM), one of the world’s leaders in science-backed nutrition solutions, announced that it has opened a new production facility in Valencia, Spain to help meet rising global demand for probiotics, postbiotics and other […]
Pharma & Human Health
Call for Experts – A Survey on Microbiome-Based Biomarker Development
The EU-funded coordination and support project “Human Microbiome Action” is seeking experts in microbiome-based biomarker development to partake in a Delphi survey. A Delphi Survey is a recognised research practice whereby experts reach a consensus […]
